graphic
abstract
highlight
mv
common
transcript
host
respons
respiratori
viral
infect
mv
could
use
clinic
diagnost
andor
prognost
biomark
im
distinguish
influenza
viral
bacteri
infect
im
correl
infect
symptomatolog
vaccin
respons
clinic
relev
respiratori
viral
signatur
defin
khatri
colleagu
identifi
host
transcript
respons
common
multipl
respiratori
virus
mv
specif
influenza
im
leverag
heterogen
present
public
dataset
signatur
distinguish
viral
bacteri
infect
im
also
distinguish
influenza
viral
infect
respiratori
virus
influenza
sar
pose
major
threat
global
health
yet
antivir
drug
difficult
develop
addit
treat
potenti
pandem
viral
strain
problemat
mani
unknown
pathogenesi
infect
current
antivir
drug
target
pathogen
enzymat
function
provid
onebugonedrug
approach
use
resourc
ineffici
often
limit
emerg
viral
resist
locarnini
warner
richman
et
al
drugdevelop
process
requir
abil
identifi
specif
host
factor
necessari
viral
growth
virul
could
also
potenti
drug
target
light
larg
unmet
need
novel
antivir
strategi
effici
solut
would
repurpos
current
approv
drug
broadspectrum
hostcent
antivir
could
impair
viral
transmiss
prevent
clinic
patholog
identifi
host
factor
target
exist
drug
requir
viral
growth
prevail
approach
studi
gene
express
profil
limit
abil
identifi
wouldb
target
broadspectrum
antivir
therapeut
mani
gene
express
microarray
studi
propos
distinct
gene
signatur
discrimin
differ
viral
infect
zaa
et
al
influenza
bacteri
infect
parnel
et
al
parnel
et
al
ramilo
et
al
howev
experi
aim
reduc
effect
variou
biolog
technic
confound
factor
much
possibl
focus
one
viral
infect
one
tissu
use
one
type
microarray
standard
singlecohort
approach
increas
risk
confound
factor
gene
express
profil
specif
tissu
technolog
demograph
inclus
criteria
respect
studi
unknown
biolog
technic
factor
parnel
et
al
parnel
et
al
ramilo
et
al
mask
broad
pathway
use
multipl
virus
establish
infect
develop
integr
multicohort
analysi
framework
leverag
heterogen
present
public
data
repositori
eg
geo
arrayexpress
turn
increas
sampl
size
allow
identif
valid
robust
reproduc
signatur
diseas
phenotyp
demonstr
util
framework
identifi
novel
drug
target
diagnost
biomark
repurpos
fdaapprov
drug
chen
et
al
khatri
et
al
li
et
al
mazur
et
al
sweeney
et
al
appli
method
two
differ
hypothes
first
obtain
common
transcript
signatur
across
respiratori
viral
infect
appli
method
three
gene
express
dataset
human
blood
sampl
three
viral
infect
influenza
human
rhinoviru
hrv
respiratori
syncyti
viru
rsv
measur
two
differ
microarray
platform
three
countri
identifi
robust
metaviru
signatur
mv
respiratori
viral
infect
test
signatur
independ
cohort
compos
blood
sampl
show
confound
sampl
tissu
treatment
viral
strain
microarray
technolog
perform
separ
multicohort
analysi
influenza
infect
studi
illustr
virusspecif
signatur
encompass
smaller
subset
gene
appli
method
five
influenza
gene
express
dataset
consist
sampl
identifi
influenza
metasignatur
im
use
addit
independ
cohort
show
influenzaspecif
signatur
abl
discrimin
symptomat
asymptomat
subject
influenza
infect
respiratori
viral
infect
patient
mix
influenza
andor
bacteri
pneumonia
bacteri
pneumonia
alon
final
bridg
gap
influenza
infect
vaccin
demonstr
influenza
infect
signatur
also
increas
significantli
influenza
vaccin
respond
compar
nonrespond
two
multicohort
analys
show
conserv
host
respons
respiratori
viral
infect
virusspecif
respons
could
distinguish
differ
viru
type
signific
potenti
use
diagnosi
treatment
viral
infect
download
microarray
gene
express
dataset
ncbi
geo
barrett
et
al
databas
compris
sampl
obtain
whole
blood
pbmc
primari
epitheli
cell
tabl
bermejomartin
et
al
franco
et
al
herberg
et
al
hu
et
al
ioannidi
et
al
li
et
al
loveday
et
al
mejia
et
al
parnel
et
al
parnel
et
al
ramilo
et
al
reghunathan
et
al
shapira
et
al
sutejo
et
al
tsang
et
al
wood
et
al
zaa
et
al
dataset
includ
healthi
control
individu
variou
viral
infect
bacteri
infect
noninfecti
systemat
inflam
effect
size
heatmap
mv
discoveri
valid
b
cohort
column
gene
row
cohort
first
row
heatmap
display
summari
effect
size
gene
discoveri
valid
cohort
gene
sort
decreas
order
summari
effect
size
discoveri
cohort
heatmap
matori
respons
syndrom
sir
individu
vaccin
influenza
vitro
transfect
experi
express
differ
viral
antigen
use
five
cohort
three
dataset
compos
sampl
studi
three
respiratori
viral
infect
identifi
potenti
common
viral
respons
tabl
herberg
et
al
hu
et
al
ioannidi
et
al
refer
studi
uniqu
gse
id
geo
dataset
set
sampl
comparison
within
dataset
cohort
unlik
singlecohort
experi
goal
control
mani
confound
factor
possibl
includ
broad
biolog
technic
heterogen
treatment
protocol
demograph
observ
popul
choos
discoveri
cohort
collect
differ
center
differ
treatment
protocol
demograph
profil
one
viral
infect
influenza
rsv
hrv
across
differ
age
group
infant
pediatr
incorpor
technic
heterogen
sampl
choos
dataset
profil
use
microarray
two
differ
manufactur
repres
differ
technolog
confound
factor
eg
length
oligonucleotid
probe
sampl
prepar
protocol
order
avoid
potenti
influenc
singl
cohort
result
due
unequ
sampl
size
unknown
confound
factor
among
cohort
perform
leaveonecohortout
analysi
hypothes
result
set
gene
significantli
differenti
express
irrespect
set
cohort
analyz
would
constitut
robust
signatur
respiratori
viral
infect
identifi
differenti
express
gene
overand
underexpress
p
fdr
figur
tabl
respiratori
viral
infect
mani
previous
identifi
differenti
express
viral
infect
oasl
tolllik
receptor
tlr
interferon
induc
transmembran
protein
ifitm
parnel
et
al
parnel
et
al
ramilo
et
al
wood
et
al
zaa
et
al
refer
set
metaviru
signatur
mv
kegg
pathway
analysi
use
ipathwayguid
draghici
et
al
khatri
et
al
tarca
et
al
mv
identifi
signific
pathway
includ
pathway
viral
infect
epsteinbarr
viru
influenza
herp
simplex
measl
tabl
signific
relev
kegg
pathway
includ
cell
cycl
nfkb
signal
tolllik
receptor
signal
lysosom
sphingolipid
metabol
next
analyz
express
mv
gene
addit
independ
cohort
consist
pbmc
whole
blood
sampl
viral
infect
sampl
control
mv
overexpress
gene
underexpress
mv
gene
statist
signific
p
valid
cohort
figur
data
indic
mv
defin
broad
immunolog
respons
host
respiratori
viral
infect
mv
specif
viral
infect
differenti
diagnosi
bacteri
versu
viral
infect
confound
similar
clinic
symptom
underli
condit
immunosuppress
extrapulmonari
complic
babcock
et
al
ison
lee
parnel
et
al
parnel
et
al
ramilo
et
al
therefor
explor
whether
mv
could
distinguish
viral
infect
bacteri
infect
first
examin
independ
cohort
children
year
age
gse
hu
et
al
sampl
defin
mv
score
differ
geometr
mean
overexpress
gene
underexpress
gene
mv
expect
mv
score
virusinfect
children
significantli
higher
virusneg
control
p
receiv
oper
characterist
roc
area
curv
auc
mv
score
significantli
higher
afebril
rsvinfect
children
febril
bacteri
infect
p
distinguish
group
high
accuraci
roc
auc
figur
result
suggest
mv
score
confound
febril
statu
children
mv
score
also
higher
anoth
independ
cohort
gse
patient
infect
sever
acut
respiratori
syndrom
sar
coronaviru
figur
interestingli
mv
score
also
higher
children
viral
infect
adenoviru
enteroviru
compar
virusneg
control
p
bacteri
infect
p
although
none
infect
use
defin
mv
figur
mv
score
also
distinguish
sampl
viral
infect
bacteri
infect
sampl
healthi
control
rel
high
accuraci
figur
indic
mv
might
broadli
applic
respiratori
virus
next
use
influenza
challeng
studi
gse
inocul
healthi
adult
evalu
chang
mv
score
cours
infect
wood
et
al
mv
score
remain
unchang
time
asymptomat
subject
shed
viru
group
howev
mv
score
increas
significantli
virusshed
symptomat
subject
hr
began
declin
toward
asymptomat
baselin
level
symptom
resolv
figur
specif
mv
score
six
nine
symptomat
volunt
higher
asymptomat
volunt
hr
inocul
figur
similarli
mv
score
symptomat
volunt
higher
asymptomat
volunt
hr
inocul
figur
median
onset
time
symptom
volunt
hr
rang
hr
hr
rang
hr
respect
henc
increas
mv
score
preced
respiratori
infect
symptom
onset
strain
distinguish
symptomat
asymptomat
volunt
high
specif
sensit
roc
auc
hr
p
hr
p
respect
figur
three
subject
one
asymptomat
two
symptomat
show
mv
score
profil
opposit
respect
group
figur
examin
individu
reveal
asymptomat
subject
follow
trajectori
similar
symptomat
group
shed
viru
origin
studi
refer
subject
asymptomat
shedder
wood
et
al
similarli
one
symptomat
subject
follow
trajectori
similar
asymptomat
group
shed
viru
therefor
refer
symptomat
nonshedd
origin
studi
result
provid
strong
evid
accuraci
mv
score
correctli
identifi
infect
individu
independ
symptom
collect
result
show
mv
common
transcript
signatur
respiratori
viral
infect
independ
subject
symptom
mv
also
abl
identifi
symptomat
subject
prior
symptom
onset
influenza
challeng
studi
higher
mv
score
virus
adenoviru
enteroviru
addit
influenza
rsv
hrv
suggest
mv
might
broadli
applic
respiratori
virus
howev
larger
systemat
analysi
divers
virus
would
necessari
identifi
core
signatur
result
also
suggest
mv
might
abl
distinguish
viral
infect
prior
symptom
onset
similar
influenza
though
addit
challeng
studi
use
virus
need
valid
number
studi
previous
report
virusand
strainspecif
signatur
hu
et
al
zaa
et
al
therefor
hypothes
despit
common
transcript
respons
respiratori
viral
infect
might
virusspecif
transcript
respons
appli
method
sever
influenza
infect
studi
see
whether
could
identifi
influenza
metasignatur
im
chose
express
profil
blood
sampl
five
cohort
three
countri
profil
use
two
type
microarray
repres
biolog
technic
heterogen
discoveri
cohort
use
sampl
healthi
individu
patient
bacteri
infect
day
preinocul
individu
control
use
sampl
influenza
infect
individu
inocul
case
identifi
gene
fdr
significantli
overexpress
tabl
supplement
experiment
procedur
although
stringent
criterion
might
left
gene
vari
express
influenza
allow
identif
reproduc
transcript
profil
found
five
influenza
discoveri
cohort
despit
presenc
signific
heterogen
gene
includ
receptor
rlr
molecul
transcript
factor
known
overexpress
influenza
infect
interferonalpha
induc
gene
transport
molecul
antivir
molecul
myxoviru
resist
gene
oligoadenyl
synthetas
guanylatebind
protein
mani
gene
shown
overexpress
influenza
infect
ramilo
et
al
confirm
valid
result
network
analysi
gene
ingenu
pathway
analysi
ipa
confirm
gene
part
network
involv
innat
viru
sens
initi
antivir
respons
pathway
figur
thu
analysi
abl
captur
known
biolog
respons
influenza
defin
gene
subset
larger
common
mv
appli
leaveonecohortout
strategi
avoid
undu
influenc
singl
cohort
result
identifi
overexpress
gene
use
stringent
fdr
gene
signific
heterogen
effect
size
p
remov
analysi
remain
gene
homogen
overexpress
patient
infect
influenza
across
discoveri
cohort
figur
tabl
network
analysi
ipa
show
gene
interconnect
form
central
axi
transcript
regul
figur
refer
gene
im
ask
whether
im
could
distinguish
influenza
bacteri
infect
similar
mv
therefor
defin
geometr
mean
im
gene
im
score
sampl
gse
parnel
et
al
im
score
influenza
pneumonia
patient
significantli
higher
healthi
control
bacteri
pneumonia
patient
noninfecti
sir
p
figur
importantli
signific
differ
im
score
influenza
pneumonia
patient
mix
pneumonia
patient
individu
influenza
bacteri
infect
data
suggest
even
concur
bacteri
infect
patient
im
score
could
still
identifi
influenza
infect
also
show
use
sampl
obtain
within
hr
hospit
im
score
identifi
influenza
pneumonia
patient
high
specif
sensit
auc
figur
result
valid
util
im
index
influenza
infect
distinguish
bacteri
infect
clinic
set
next
compar
im
score
pbmc
pediatr
patient
age
year
influenza
bacteri
infect
staphylococcu
aureu
streptococcu
pneumonia
escherichia
coli
independ
cohort
gse
ramilo
et
al
despit
presenc
biolog
age
pathogen
antibiot
technolog
three
microarray
platform
confound
factor
im
score
patient
influenza
infect
significantli
higher
healthi
control
patient
bacteri
infect
p
figur
high
specif
sensit
distinguish
influenza
patient
varieti
bacteri
infect
auc
rang
figur
lack
statist
signific
figur
artifact
small
sampl
size
n
pneumonia
group
outlier
collect
result
provid
strong
evid
im
abl
specif
distinguish
influenza
infect
bacteri
infect
confound
age
array
technolog
use
profil
im
score
patient
viral
infect
differ
virusneg
control
patient
bacteri
infect
figur
sar
coronaviru
figur
fact
im
score
significantli
lower
virusinfect
patient
virusneg
control
p
figur
contrast
mv
score
significantli
higher
cohort
result
suggest
im
might
specif
influenza
none
patient
cohort
infect
influenza
therefor
compar
im
score
influenzainfect
patient
patient
respiratori
viral
infect
rsv
hrv
use
three
dataset
gse
dataset
profil
whole
blood
sampl
children
age
year
note
influenzainfect
sampl
healthi
control
sampl
use
discoveri
cohort
identif
im
tabl
im
score
significantli
higher
influenza
sampl
compar
rsv
sampl
p
margin
signific
p
figur
influenza
sampl
also
im
score
significantli
higher
hrv
sampl
p
figur
notabl
three
dataset
mv
score
subject
viral
infect
significantli
higher
healthi
control
p
similar
compar
p
figur
except
hrv
rsv
p
figur
data
confirm
gene
im
abl
accur
discrimin
influenza
viral
infect
im
score
distinguish
symptomat
asymptomat
individu
high
specif
sensit
similar
mv
explor
chang
im
score
inocul
influenza
challeng
studi
gse
two
influenza
bacteri
pneumonia
cohort
gse
pneumonia
cohort
profil
longitudin
sampl
obtain
patient
within
hr
admiss
intens
care
unit
whisker
repres
confid
interv
orang
diamond
repres
overal
combin
mean
differ
given
gene
width
diamond
repres
confid
interv
overal
mean
differ
l
network
analysi
ingenu
pathway
analysi
show
gene
part
singl
regulatori
network
blue
node
network
repres
im
gene
red
node
repres
gene
significantli
overexpress
influenza
infect
includ
im
challeng
studi
allow
analysi
im
score
initi
acut
phase
infect
wherea
pneumonia
cohort
allow
analysi
im
score
patient
establish
infect
progress
recoveri
resolut
symptom
similar
mv
score
im
score
unchang
asymptomat
volunt
inocul
increas
significantli
symptomat
patient
figur
furthermor
increas
averag
im
score
symptomat
volunt
also
preced
symptom
onset
group
exampl
im
score
symptomat
volunt
higher
asymptomat
volunt
hr
inocul
auc
figur
suggest
im
score
correctli
identifi
symptomat
volunt
prior
symptom
onset
volunt
show
symptom
later
group
wood
et
al
im
score
also
began
increas
later
time
point
compar
group
achiev
maximum
discrimin
symptomat
asymptomat
volunt
hr
auc
figur
also
prior
symptom
onset
volunt
thu
kinet
im
gene
express
might
provid
prognost
capabl
clinic
track
potenti
morbid
known
exposur
identifi
suscept
individu
prior
symptom
onset
howev
mv
im
behav
differ
challeng
studi
mv
achiev
higher
discriminatori
power
im
time
point
inocul
figur
instanc
hr
inocul
roc
auc
cohort
mv
im
respect
similarli
hr
inocul
roc
auc
mv
im
respect
furthermor
im
score
symptomat
volunt
remain
higher
asymptomat
volunt
end
time
cours
figur
contrast
mv
score
began
decreas
toward
asymptomat
baselin
level
time
point
figur
result
suggest
mv
common
transcript
respons
viral
infect
turn
earlier
influenzaspecif
respons
also
return
baselin
earlier
influenzaspecif
respons
pneumonia
cohort
analysi
show
im
score
remain
unchang
baselin
healthi
control
patient
bacteri
pneumonia
sir
figur
contrast
im
score
influenza
pneumonia
patient
significantli
higher
bacteri
pneumonia
p
p
time
admiss
progress
decreas
time
influenza
pneumonia
patient
p
p
figur
mean
im
score
mix
pneumonia
patient
defin
bacteri
influenza
infect
also
significantli
higher
admiss
decreas
time
indistinguish
influenza
pneumonia
patient
suggest
im
score
confound
coinfect
bacteri
pathogen
ultim
goal
influenza
vaccin
induc
immun
respons
infect
induc
memori
respons
without
correspond
patholog
despit
larg
number
influenza
infect
mejia
et
al
parnel
et
al
ramilo
et
al
vaccin
franco
et
al
furman
et
al
nakaya
et
al
tsang
et
al
studi
common
transcript
signatur
influenza
vaccin
propos
therefor
explor
chang
im
score
influenza
vaccin
three
independ
cohort
individu
tsang
et
al
gse
divid
vaccin
fluvirin
novarti
healthi
individu
three
group
low
moder
high
respond
defin
lowest
th
percentil
st
th
percentil
th
percentil
microneutr
titer
respect
im
score
increas
significantli
high
pair
test
p
moder
pair
test
p
respond
low
respond
pair
test
p
day
vaccin
compar
day
figur
unlik
tsang
et
al
typic
vaccin
respond
nonrespond
defin
base
chang
hemagglutinationinhibit
hai
assay
titer
day
vaccin
therefor
use
definit
categor
respond
nonrespond
two
independ
vaccin
cohort
gse
franco
et
al
explor
whether
im
score
show
differ
vaccin
respond
nonrespond
prior
mark
cohort
femal
im
score
increas
significantli
day
vaccin
respond
pair
test
p
pair
test
p
nonrespond
pair
test
p
figur
similarli
cohort
male
im
score
increas
significantli
respond
pair
test
p
day
vaccin
figur
howev
im
score
also
increas
significantli
nonrespond
pair
test
p
male
cohort
although
increas
nonrespond
vaccin
lower
respond
figur
use
increas
microneutr
titer
day
vaccin
defin
respond
im
score
show
similar
result
cohort
figur
result
show
im
score
increas
significantli
vaccin
respond
could
potenti
serv
marker
success
vaccin
investig
whether
im
respons
could
seen
epitheli
cell
target
cell
popul
influenza
replic
inde
three
independ
dataset
sampl
im
score
increas
significantli
cell
line
epitheli
origin
influenza
infect
figur
next
compar
im
score
primari
human
bronchial
epitheli
cell
transfect
viral
rna
vrna
isol
influenza
particl
result
product
viral
protein
particl
treatment
interferon
beta
ifnb
identifi
respons
mediat
type
interferon
ifn
infect
mutant
viru
lack
gene
normal
inhibit
vrnaor
ifnbinduc
pathway
host
cell
im
score
increas
significantli
strategi
figur
kinet
magnitud
increas
im
score
reflect
hierarchi
influenza
viru
detect
epitheli
cell
host
respons
exampl
hr
infect
im
score
lowest
infect
wildtyp
influenza
viru
howev
magnitud
chang
averag
im
score
hr
infect
higher
cell
expos
influenza
viral
rna
infect
influenza
viru
lack
protein
treat
ifnb
probabl
due
absenc
protein
inhibit
vrnaor
ifnbinduc
pathway
condit
furthermor
increas
im
score
fastest
cell
treat
ifnb
hr
slowest
infect
wildtyp
influenza
viru
without
protein
hr
intermedi
transfect
viral
rna
hr
taken
togeth
differ
time
averag
im
score
begin
rise
suggest
im
consist
host
respons
gene
directli
indirectli
target
influenza
viru
suppress
host
respons
evad
detect
dampen
effect
ifnb
goal
studi
integr
gene
express
data
multipl
heterogen
sourc
defin
conserv
host
respons
respiratori
viral
infect
one
specif
influenza
dual
goal
could
use
multipl
set
determin
like
prognosi
viral
infect
diagnosi
specif
viral
infect
identifi
vaccin
respond
uncov
new
biolog
pathway
possibl
drug
target
studi
use
previous
describ
multicohort
analysi
framework
analyz
independ
cohort
dataset
consist
sampl
collect
countri
repres
infect
virus
bacteria
whole
blood
pbmc
epitheli
cell
identifi
mv
im
robustli
consist
differenti
express
across
age
gender
clinic
time
cours
ill
sever
result
show
mv
abl
distinguish
virusinfect
patient
bacteri
infect
healthi
control
high
accuraci
identifi
influenzainfect
subject
risk
ill
onset
clinic
symptom
although
clinic
util
mv
might
limit
due
larg
number
gene
signatur
provid
potenti
start
point
simpler
diagnost
gene
set
importantli
identifi
novel
pathway
better
understand
viral
host
respons
identifi
target
novel
antivir
therapi
also
show
im
specif
influenza
infect
abl
distinguish
influenza
infect
bacteri
infect
predict
clinic
ill
challeng
studi
prognost
influenza
pneumonia
patient
correl
gene
express
chang
subject
respond
influenza
vaccin
show
differ
dynam
male
femal
influenza
vaccin
although
sever
group
propos
influenza
infectionspecif
gene
set
littl
overlap
among
instanc
although
total
number
gene
report
studi
rang
none
im
gene
report
studi
exampl
report
gene
report
overexpress
seven
dataset
wherea
report
overexpress
one
dataset
observ
discrep
report
result
influenza
infect
across
multipl
studi
also
underscor
import
advantag
use
rigor
integr
multicohort
analysi
approach
enabl
research
leverag
larg
amount
publicli
avail
dataset
biolog
technolog
heterogen
present
among
creat
big
data
multipl
small
data
better
repres
heterogen
observ
realworld
popul
approach
previous
found
effect
uncov
gene
consist
express
profil
mechanist
diagnost
therapeut
chen
et
al
khatri
et
al
li
et
al
mazur
et
al
sweeney
et
al
identif
valid
robust
reproduc
signatur
across
multipl
independ
cohort
could
turn
enabl
systemat
global
analys
instanc
none
exist
studi
influenza
infect
vaccin
explor
propos
signatur
relat
infect
vaccin
furman
et
al
hu
et
al
li
et
al
nakaya
et
al
parnel
et
al
parnel
et
al
ramilo
et
al
tsang
et
al
wood
et
al
contrast
explor
im
three
influenza
vaccin
studi
show
signatur
also
correl
influenza
vaccin
respons
therebi
bridg
gap
influenza
infect
vaccin
im
diagnost
prognost
influenzainfect
patient
correl
vaccin
respons
compel
clinic
data
shown
men
women
differ
innat
humor
cellmedi
respons
viral
vaccin
klein
et
al
exampl
testosteron
immunosuppress
role
respons
influenza
vaccin
furman
et
al
line
im
score
chang
significantli
respond
day
male
day
femal
vaccin
result
suggest
effect
sex
differ
immun
respons
might
nuanc
male
respond
sooner
vaccin
compar
femal
sex
differ
might
also
effect
dynam
immun
respons
magnitud
result
suggest
futur
vaccin
studi
design
sampl
subject
frequent
first
day
vaccin
understand
sex
differ
immun
respons
vaccin
jenner
young
previous
carri
analysi
sampl
studi
howev
contrari
integr
multicohort
analysi
focus
identifi
robust
signatur
viral
infect
analysi
focus
identifi
common
transcript
respons
pathogen
infect
irrespect
sourc
bacteri
viral
furthermor
analysi
reli
cluster
gene
express
pattern
across
studi
identifi
common
host
respons
gene
gene
ubiquit
express
across
dataset
instead
employ
establish
statist
framework
account
variabl
gene
express
array
type
number
sampl
within
studi
addit
sampl
use
analysi
identif
mv
im
peripher
blood
sampl
wherea
jenner
young
use
sampl
variou
sourc
includ
cell
line
sort
immun
cell
tissu
liver
skin
astrocyt
fibroblast
etc
import
differ
studi
design
mani
gene
identifi
jenner
young
mediat
inflamm
significantli
differenti
express
analysi
probabl
overexpress
bacteri
viral
infect
compar
uninfect
individu
howev
number
ifninduc
gene
identifi
also
overexpress
analysi
suggest
although
gene
overexpress
bacteri
viral
infect
greater
chang
express
influenza
infect
bacteri
infect
mani
gene
isg
report
literatur
howev
depend
cell
type
ifn
dose
time
treatment
number
isg
vari
schoggin
rice
thu
remain
unclear
gene
relev
influenza
infect
herein
identifi
concis
influenza
respons
signatur
mani
isg
inde
ifnb
treatment
hbec
suggest
gene
im
stimul
ifn
find
indic
wherea
isg
common
element
among
signatur
concis
specif
gene
subset
featur
importantli
respons
influenza
although
im
identifi
use
whole
blood
pbmc
sampl
im
gene
also
overexpress
influenza
infect
primari
human
bronchial
epitheli
cell
lung
adenocarcinoma
cell
line
result
provid
evid
conserv
respons
influenza
infect
identifi
correl
system
immun
respons
blood
epithelium
onset
infect
observ
ioannidi
et
al
howev
im
gene
overexpress
vitro
studi
exampl
expect
differenti
express
sinc
express
specif
lymphocyt
et
al
sandovalmont
santosargumedo
result
suggest
im
respons
influenza
infect
present
circul
blood
separ
tissu
type
paper
limit
first
mv
gene
set
might
includ
mani
gene
allow
simpl
clinic
test
optim
might
need
reduct
practic
second
im
signatur
specif
influenza
viral
infect
data
avail
clinic
infect
similar
influenza
infect
ie
parainfluenza
infect
would
need
test
final
prospect
test
need
gene
set
common
mv
across
multipl
viral
infect
specif
im
influenza
infect
suggest
number
potenti
applic
first
mv
could
serv
start
point
identifi
broad
host
factor
target
develop
broadspectrum
antivir
drug
exist
antivir
drug
base
onedrugonebug
philosophi
ineffici
ineffect
virus
often
mutat
develop
drug
resist
novel
viral
strain
emerg
anim
carrier
instead
develop
antivir
drug
target
host
factor
involv
multipl
respiratori
viral
infect
could
provid
protect
broader
group
virus
effect
novel
strain
second
im
score
use
clinic
distinguish
influenza
infect
regardless
whether
concurr
bacteri
pneumonia
could
help
clinician
determin
whether
initi
antivir
treatment
patient
potenti
coinfect
third
im
score
use
object
measur
vaccin
respons
result
influenzavaccin
individu
show
im
score
increas
significantli
respond
remain
unchang
nonrespond
final
specif
im
influenza
compar
respiratori
virus
enabl
identif
virusspecif
immun
metric
appli
vaccin
natur
infect
studi
might
start
place
studi
differenti
biolog
influenza
infect
gener
abil
defin
metric
immun
system
done
goe
beyond
concept
biomark
provid
mean
measur
understand
function
potenti
mechanist
pathophysiolog
relationship
diseasespecif
clinic
cohort
data
collect
preprocess
entir
analysi
perform
publicli
avail
data
download
microarray
gene
express
dataset
ncbi
geo
compris
sampl
deriv
whole
blood
pbmc
epitheli
cell
cell
line
tabl
sampl
dataset
repres
differ
biolog
condit
includ
viral
infect
influenza
rsv
hrv
sar
adenoviru
enteroviru
bacteri
infect
e
coli
aureu
pneumoni
salmonella
nonpathogen
systemat
inflammatori
respons
healthi
control
incorpor
technic
heterogen
analysi
choos
dataset
profil
use
microarray
differ
manufactur
dataset
except
one
gse
whole
blood
pbmc
sampl
obtain
patient
without
viral
infect
wide
rang
age
fewer
month
year
furthermor
sampl
independ
collect
profil
center
countri
supplement
experiment
procedur
provid
brief
descript
dataset
dataset
verifi
express
normal
studi
use
sampl
phenotyp
defin
primari
public
sourc
studi
microarray
probe
dataset
map
entrez
gene
identifi
id
facilit
integr
analysi
probe
match
one
gene
express
data
probe
expand
add
one
record
map
gene
ramasami
et
al
appli
two
metaanalysi
method
describ
previou
public
figur
tabl
combin
effect
size
combin
p
valu
chen
et
al
khatri
et
al
sweeney
et
al
estim
effect
size
gene
dataset
hedg
adjust
g
multipl
probe
map
gene
effect
size
gene
summar
via
fix
effect
inversevari
model
studyspecif
effect
size
gene
combin
singl
meta
effects
use
linear
combin
studyspecif
effect
size
f
studyspecif
effect
size
weight
invers
varianc
correspond
studi
comput
meta
effects
p
valu
correct
multipl
hypothes
test
via
benjaminihochberg
fals
discoveri
rate
fdr
correct
benjamini
hochberg
signific
gene
identifi
via
zstatist
use
fisher
sum
log
method
fisher
metaanalysi
combin
p
valu
gene
sum
logarithm
onesid
hypothesi
test
p
valu
across
k
studi
compar
result
c
distribut
degre
freedom
order
avoid
influenc
dataset
larg
sampl
size
result
remov
one
dataset
time
appli
metaanalysi
method
iter
filter
heterogen
dataset
identifi
mv
differ
virus
induc
variou
gene
differ
level
howev
ensur
signific
heterogen
p
effect
size
across
dataset
im
defin
mv
score
sampl
geometr
mean
normal
express
overexpress
gene
minu
underexpress
gene
defin
im
score
sampl
geometr
mean
normal
express
overexpress
gene
scale
center
mv
im
score
sampl
given
dataset
mean
standard
deviat
enabl
comparison
dataset
use
wilcoxonmannwhitney
wilcoxon
anova
test
whether
statist
signific
differ
mv
im
score
two
group
dataset
contain
neg
valu
comput
geometr
mean
possibl
dataset
use
mean
normal
express
valu
comput
mv
im
score
perform
function
pathway
analysi
via
ipathwayguid
draghici
et
al
khatri
et
al
tarca
et
al
metaeffect
size
across
viral
infect
use
fold
chang
ipathwayguid
identifi
signific
pathway
use
fdr
threshold
identifi
signific
pathway
perform
network
analysi
influenzaspecif
gene
ipa
option
includ
direct
relationship
avoid
spuriou
connect
caus
indirect
relat
direct
relationship
ipa
result
public
cite
experiment
evid
interact
infectiona
metaanalysi
genom
signatur
circul
leukocyt
plo
one
parnel
gp
mclean
booth
dr
armstrong
nj
nalo
huang
sj
manak
j
tang
w
tam
oy
chan
tang
bm
distinct
influenza
infect
signatur
blood
transcriptom
patient
sever
communityacquir
pneumonia
crit
care
ramasami
mondri
holm
cc
altman
dg
key
issu
conduct
metaanalysi
gene
express
microarray
dataset
plo
med
ramilo
allman
w
chung
w
mejia
ardura
glaser
c
wittkowski
km
piquera
b
banchereau
j
palucka
ak
chaussabel
gene
express
pattern
blood
leukocyt
discrimin
patient
acut
infect
blood
reghunathan
r
jayap
hsu
ly
chng
hh
tai
leung
bp
melendez
aj
express
profil
immun
respons
gene
patient
sever
acut
respiratori
syndrom
bmc
immunol
richman
dd
morton
sc
wrin
hellmann
n
berri
shapiro
mf
bozzett
sa
preval
antiretrovir
drug
resist
unit
state
aid
sandovalmont
c
santosargumedo
l
express
select
activ
subset
matur
cell
reduc
prolifer
improv
potenti
produc
cytokin
j
leukoc
biol
cell
sutejo
r
yeo
ds
mya
mz
hui
c
xia
j
ko
cheung
pcf
tan
bh
sugru
rj
activ
type
iii
interferon
signal
pathway
occur
lung
epitheli
cell
infect
low
pathogen
avian
influenza
virus
plo
one
sweeney
te
shidham
wong
hr
khatri
p
comprehens
timecoursebas
multicohort
analysi
sepsi
steril
inflamm
reveal
robust
diagnost
gene
set
sci
transl
med
tarca
al
draghici
khatri
p
hassan
ss
mittal
p
kim
js
kim
cj
kusanov
jp
romero
r
novel
signal
pathway
impact
analysi
bioinformat
tsang
js
schwartzberg
pl
kotliarov
biancotto
xie
z
germain
rn
wang
e
oln
mj
narayanan
gold
h
et
al
baylor
hipc
center
chi
consortium
global
analys
human
immun
variat
reveal
baselin
predictor
postvaccin
respons
cell
wilcoxon
f
individu
comparison
rank
method
jstor
biometr
wood
cw
mcclain
mt
chen
zaa
ak
nicholson
bp
varkey
j
veldman
kingsmor
sf
huang
lambkinwilliam
r
et
al
host
transcript
signatur
presymptomat
detect
infect
human
expos
influenza
plo
one
zaa
ak
chen
varkey
j
veldman
hero
ao
luca
j
huang
turner
r
gilbert
lambkinwilliam
r
et
al
entir
analysi
perform
use
publicli
avail
data
download
microarray
gene
express
dataset
ncbi
geo
compris
sampl
deriv
whole
blood
pbmc
epitheli
cell
cell
line
supplementari
tabl
sampl
dataset
repres
differ
biolog
condit
includ
viral
infect
influenza
rsv
hrv
sar
adenoviru
enteroviru
bacteri
infect
e
coli
aureu
pneumoni
salmonella
nonpathogen
systemat
inflammatori
respons
healthi
control
incorpor
technic
heterogen
analysi
choos
dataset
profil
use
microarray
differ
manufactur
dataset
except
one
whole
blood
pbmc
sampl
obtain
patient
without
viral
infect
wide
rang
age
less
month
year
furthermor
sampl
independ
collect
profil
center
seven
countri
dataset
verifi
express
data
avail
download
ncbi
geo
databas
normal
identifi
sampl
given
viral
infect
influenza
rsv
hrv
normal
independ
viral
infect
dataset
therefor
download
raw
data
file
gse
geo
normal
sampl
within
dataset
togeth
use
gcrma
studi
use
sampl
phenotyp
defin
primari
public
sourc
studi
microarray
probe
data
set
map
entrez
gene
identifi
id
facilit
integr
analysi
probe
match
one
gene
express
data
probe
expand
add
one
record
map
gene
two
major
hypothes
paper
first
exist
common
host
respons
clinic
respiratori
viral
infect
specif
viru
type
may
reflect
ill
sever
second
virusspecif
signatur
also
exist
separ
differ
viral
infect
end
perform
two
multicohort
analys
term
metaviru
signatur
mv
influenza
metasignatur
im
mv
analysi
incorpor
dataset
multipl
respiratori
virus
im
analysi
examin
influenza
unlik
convent
biolog
experi
sought
repres
biolog
technic
heterogen
observ
popul
choos
cohort
collect
differ
center
profil
use
differ
technolog
chose
three
dataset
creat
five
discoveri
cohort
cohort
contain
sampl
one
type
viral
infect
healthi
control
instanc
creat
two
cohort
compar
healthi
control
sampl
sampl
patient
influenza
infect
compar
healthi
control
sampl
sampl
patient
rsv
infect
healthi
control
sampl
common
two
cohort
similarli
creat
two
cohort
compar
sampl
influenza
rsv
infect
patient
healthi
control
final
compar
hrv
sampl
healthi
control
remain
sampl
viral
bacteri
infect
use
valid
cohort
mv
figur
similar
approach
took
select
data
set
discov
mv
signatur
sought
repres
biolog
technic
heterogen
observ
popul
repres
phenotyp
divers
choos
sampl
follow
cohort
control
healthi
day
preinocul
bacteri
pneumonia
case
postinocul
influenza
pneumonia
chose
dataset
collect
center
differ
countri
repres
differ
biolog
confound
factor
popul
genet
treatment
protocol
infecti
agent
also
incorpor
technic
heterogen
sampl
choos
dataset
profil
use
differ
microarray
platform
identifi
five
dataset
consist
blood
sampl
satisfi
criteria
preinocul
sampl
influenza
use
control
sampl
postinocul
sampl
influenza
use
case
irrespect
whether
symptomat
asymptomat
inocul
bacteri
pneumonia
sampl
prevaccin
sampl
use
control
sever
influenza
day
postvaccin
sampl
use
case
sampl
patient
influenza
pneumonia
healthi
control
use
irrespect
day
sampl
taken
rest
sampl
dataset
bacteri
pneumonia
mixedpneumonia
noninfecti
systemat
inflammatori
respons
use
valid
im
figur
use
sampl
healthi
control
influenzainfect
sampl
sampl
rsvinfect
patient
use
valid
specif
im
influenza
infect
figur
appli
two
metaanalysi
method
describ
previou
public
supplementari
figur
supplementari
tabl
framework
analysi
subset
total
dataset
select
use
discoveri
cohort
describ
supplementari
tabl
analyz
use
two
metaanalysi
method
combin
effect
size
ii
combin
pvalu
estim
effect
size
gene
data
set
hedg
adjust
g
multipl
probe
map
gene
effect
size
gene
summar
use
fix
effect
inversevari
model
studyspecif
effect
size
gene
combin
singl
meta
effects
use
linear
combin
studyspecif
effect
size
fi
studyspecif
effect
size
weight
invers
varianc
correspond
studi
comput
meta
effects
pvalu
correct
multipl
hypothes
test
use
benjaminihochberg
fals
discoveri
rate
fdr
correct
signific
gene
identifi
use
zstatist
use
fisher
sum
log
method
metaanalysi
combin
pvalu
gene
sum
logarithm
onesid
hypothesi
test
pvalu
across
k
studi
compar
result
distribut
degre
freedom
dataset
larg
sampl
size
significantli
influenc
metaanalysi
result
therefor
perform
metaanalysi
remov
one
dataset
time
order
avoid
influenc
singl
dataset
identifi
mv
im
appli
metaanalysi
method
iter
use
fdr
fdr
iter
mv
im
respect
identifi
differenti
express
gene
overexpress
underexpress
across
viral
infect
overexpress
gene
across
influenzainfect
dataset
allow
signific
heterogen
identifi
mv
differ
virus
may
induc
variou
gene
differ
level
howev
ensur
signific
heterogen
p
effect
size
across
dataset
im
defin
mv
score
sampl
geometr
mean
normal
express
overexpress
gene
minu
underexpress
gene
defin
im
score
sampl
geometr
mean
normal
express
overexpress
gene
scale
center
mv
im
score
sampl
given
dataset
mean
standard
deviat
enabl
comparison
dataset
use
wilcoxonmannwhitney
anova
test
whether
statist
signific
differ
mv
im
score
two
group
dataset
contain
neg
valu
comput
geometr
mean
possibl
dataset
use
mean
normal
express
valu
comput
mv
im
score
supplementari
fig
refer
fig
perform
im
distinguish
symptomat
asymptomat
subject
roc
im
score
distinguish
symptomat
asymptomat
subject
inocul
influenza
b
influenza
